Cardio-obstetrics: Recognizing and managing cardiovascular complications of pregnancy

REFERENCES

1. 1.↵
   1. MacDorman MF,
   2. Declercq E,
   3. Cabral H,
   4. Morton C

   . Recent increases in the US maternal mortality rate: disentangling trends from measurement issues. Obstet Gynecol 2016; 128(3):447–455. doi:10.1097/AOG.0000000000001556

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Berg CJ,
   2. Callaghan WM,
   3. Syverson C,
   4. Henderson Z

   . Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol 2010; 116(6):1302–1309. doi:10.1097/AOG.0b013e3181fdfb11

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Creanga AA,
   2. Berg CJ,
   3. Syverson C,
   4. Seed K,
   5. Bruce FC,
   6. Callaghan WM

   . Pregnancy-related mortality in the United States, 2006–2010. Obstet Gynecol 2015; 125(1):5–12. doi:10.1097/AOG.0000000000000564

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Freedman RL,
   2. Lucas DN

   . MBRRACE-UK: saving lives, improving mothers’ care—implications for anaesthetists. Int J Obstet Anesth 2015; 24(2):161–173. doi:10.1016/j.ijoa.2015.03.004

   OpenUrlCrossRef
5. 5.↵
   1. Burlingame J,
   2. Horiuchi B,
   3. Ohana P,
   4. Onaka A,
   5. Sauvage LM

   . The contribution of heart disease to pregnancy-related mortality according to the pregnancy mortality surveillance system. J Perinatol 2012; 32(3):163–169. doi:10.1038/jp.2011.74

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Hameed AB,
   2. Lawton ES,
   3. McCain CL, et al

   . Pregnancy-related cardiovascular deaths in California: beyond peripartum cardiomyopathy. Am J Obstet Gynecol 2015; 213(3):379.e1–e10. doi:10.1016/j.ajog.2015.05.008

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Williams RA

   . Cardiovascular disease in African American women: a health care disparities issue. J Natl Med Assoc 2009; 101(6):536–540. pmid:19585921

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Creanga AA,
   2. Bateman BT,
   3. Kuklina EV,
   4. Callaghan WM

   . Racial and ethnic disparities in severe maternal morbidity: a multistate analysis, 2008–2010. Am J Obstet Gynecol 2014; 210(5):435.e1–e8. doi:10.1016/j.ajog.2013.11.039

   OpenUrlCrossRef
9. 9.↵
   1. Harper M,
   2. Dugan E,
   3. Espeland M,
   4. Martinez-Borges A,
   5. McQuellon C

   . Why African-American women are at greater risk for pregnancy-related death. Ann Epidemiol 2007; 17(3):180–185. doi:10.1016/j.annepidem.2006.10.004

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Nelson A

    . Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc 2002; 94(8):666–668. pmid:12152921

    OpenUrlPubMed
11. 11.↵
    1. Ventura SJ,
    2. Mosher WD,
    3. Curtin SC,
    4. Abma JC,
    5. Henshaw S

    . Trends in pregnancies and pregnancy rates by outcome: estimates for the United States, 1976–96. Vital Health Stat 21 2000; (56): 1–47. pmid:10740440

    OpenUrlPubMed
12. 12.↵
    1. Mathews TJ,
    2. Hamilton BE

    . Mean age of mothers is on the rise: United States, 2000–2014. NCHS Data Brief 2016; (232):1–8. pmid:26828319

    OpenUrlPubMed
13. 13.↵
    1. Martin JA,
    2. Hamilton BE,
    3. Osterman MJ,
    4. Driscoll AK,
    5. Mathews TJ

    . Births: final data for 2015. Natl Vital Stat Rep 2017; 66(1):1. pmid:28135188

    OpenUrlPubMed
14. 14.↵
    1. Martin JA,
    2. Hamilton BE,
    3. Osterman MJK,
    4. Driscoll AK,
    5. Drake P

    . Births: final data for 2017. Natl Vital Stat Rep 2018; 67(8):1–50. pmid:30707672

    OpenUrlPubMed
15. 15.↵
    1. Central Intelligence Agency

    . The World Factbook. Mother’s mean age at first birth. https://www.cia.gov/library/publications/the-world-factbook/fields/352.html. Accessed December 10, 2019.
16. 16.↵
    1. Barclay K,
    2. Myrskyla M

    . Advanced maternal age and offspring outcomes: reproductive aging and counterbalancing period trends. Population and Development Review 2016; 42(1):69–94.

    OpenUrl
17. 17.↵
    1. Gilboa SM,
    2. Devine OJ,
    3. Kucik JE, et al

    . Congenital heart defects in the United States: estimating the magnitude of the affected population in 2010. Circulation 2016; 134(2):101–109. doi:10.1161/CIRCULATIONAHA.115.019307

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Hoffman JI,
    2. Kaplan S

    . The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39(12):1890–1900. pmid:12084585

    OpenUrlFREE Full Text
19. 19.↵
    1. Thompson JL,
    2. Kuklina EV,
    3. Bateman BT,
    4. Callaghan WM,
    5. James AH,
    6. Grotegut CA

    . Medical and obstetric outcomes among pregnant women with congenital heart disease. Obstet Gynecol 2015; 126(2):346–354. doi:10.1097/AOG.0000000000000973

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Verheugt CL,
    2. Uiterwaal CS,
    3. van der Velde ET, et al

    . Mortality in adult congenital heart disease. Eur Heart J 2010; 31(10):1220–1229. doi:10.1093/eurheartj/ehq032

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Benjamin EJ,
    2. Virani SS,
    3. Callaway CW, et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee

    . Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation 2018; 137(12):e67–e492. doi:10.1161/CIR.0000000000000558.

    OpenUrlFREE Full Text
22. 22.↵
    1. Hunter S,
    2. Robson SC

    . Adaptation of the maternal heart in pregnancy. Br Heart J 1992; 68(6):540–543. doi:10.1136/hrt.68.12.540

    OpenUrlFREE Full Text
23. 23.↵
    1. Nelson-Piercy C

    . Handbook of Obstetric Medicine. 2nd Ed. London, UK: Taylor & Francis Group; 2002.
24. 24.↵
    1. James CF,
    2. Banner T,
    3. Caton D

    . Cardiac output in women undergoing cesarean section with epidural or general anesthesia. Am J Obstet Gynecol 1989; 160(5 Pt 1):1178–1184. pmid:2729392

    OpenUrlPubMed
25. 26.↵
    1. Crapo RO

    . Normal cardiopulmonary physiology during pregnancy. Clin Obstet Gynecol 1996; 39(1):3–16. pmid:8635306

    OpenUrlCrossRefPubMed
26. 25.↵
    1. Fujitani S,
    2. Baldisseri MR

    . Hemodynamic assessment in a pregnant and peripartum patient. Crit Care Med 2005; 33(10 suppl):S354–S361. pmid:16215359

    OpenUrlPubMed
27. 27.↵
    1. Heidemann BH,
    2. McLure JH

    . Changes in maternal physiology during pregnancy. CEPD Reviews. Br J Anaesth 2003; 3(3):65–68. doi:10.1093/bjacepd/mkg065

    OpenUrlCrossRef
28. 28.↵
    1. Siu SC,
    2. Sermer M,
    3. Harrison DA, et al

    . Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 1997; 96(9):2789–2794. pmid:9386139

    OpenUrlAbstract/FREE Full Text
29. 29.↵
    1. Clark SL

    . Cardiac disease in pregnancy. Crit Care Clin 1991; 7(4):777–797. pmid:1747800

    OpenUrlPubMed
30. 30.↵
    1. Warnes CA,
    2. Williams RG,
    3. Bashore TM, et al

    . ACC/AHA 2008 guidelines for the management of adults with congenital heart disease. J Am Coll Cardiol 2008; 52(23):e143–e263. doi:10.1016/j.jacc.2008.10.001

    OpenUrlFREE Full Text
31. 31.↵
    1. Sessa M,
    2. Mascolo A,
    3. Callréus T,
    4. Capuano A,
    5. Rossi F,
    6. Anderson M

    . Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase. Sci Rep 2019; 9:7236.

    OpenUrl
32. 32.↵
    1. Lima FV,
    2. Yang J,
    3. Xu J,
    4. Stergiopoulos K

    . National trends and in-hospital outcomes in pregnant women with heart disease in the United States. Am J Cardiol 2017; 119(10):1694–1700. doi:10.1016/j.amjcard.2017.02.003

    OpenUrlCrossRef
33. 33.↵
    1. Anthony J,
    2. Sliwa K

    . Decompensated heart failure in pregnancy. Card Fail Rev 2016; 2(1):20–26. doi:10.15420/cfr.2015:24:2

    OpenUrlCrossRef
34. 34.↵
    1. Thorne S,
    2. MacGregor A,
    3. Nelson-Piercy C

    . Risks of contraception and pregnancy in heart disease. Heart 2006; 92(10):1520–1525. doi:10.1136/hrt.2006.095240

    OpenUrlFREE Full Text
35. 35.↵
    1. Olsson KM,
    2. Channick R

    . Pregnancy in pulmonary arterial hypertension. Eur Respir Rev 2016; 25(142):431–437. doi:10.1183/16000617.0079-2016

    OpenUrlAbstract/FREE Full Text
36. 36.↵
    1. Bonnin M,
    2. Mercier FJ,
    3. Sitbon O, et al

    . Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 2005; 102:(6)1133–1137. pmid:15915025

    OpenUrlCrossRefPubMed
37. 37.
    1. Kiely DG,
    2. Condliffe R,
    3. Wilson VJ,
    4. Gandhi SV,
    5. Elliot CA

    . Pregnancy and pulmonary hypertension: a practical approach to management. Obstet Med 2013; 6(4):144–154. doi:10.1177/1753495X13495193

    OpenUrlCrossRef
38. 38.↵
    1. Pieper PG,
    2. Hoendermis ES

    . Pregnancy in women with pulmonary hypertension. Neth Heart J 2011; 19(12):504–508. doi:10.1007/s12471-011-0219-9

    OpenUrlCrossRefPubMed
39. 39.↵
    1. Webster LM,
    2. Myers JE,
    3. Nelson-Piercy C, et al

    . Labetalol versus nifedipine as antihypertensive treatment for chronic hypertension in pregnancy: a randomized controlled trial. Hypertension 2017; 70(5):915–922. doi:10.1161/HYPERTENSIONAHA.117.09972

    OpenUrlCrossRef
40. 40.↵
    1. European Society of Gynecology (ESG); Association for European Paediatric Cardiology (AEPC); German Society for Gender Medicine (DGesGM);
    2. Regitz-Zagrosek V,
    3. Blomstrom Lundqvist C,
    4. Borghi C, et al

    . ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011; 32(24):3147–3197. doi:10.1093/eurheartj/ehr218

    OpenUrlCrossRefPubMed
41. 41.↵
    1. Ness RB,
    2. Markovic N,
    3. Bass D,
    4. Harger G,
    5. Roberts JM

    . Family history of hypertension, heart disease, and stroke among women who develop hypertension in pregnancy. Obstet Gynecol 2003; 102(6):1366–1371. pmid:14662228

    OpenUrlCrossRefPubMed
42. 42.↵
    1. Irgens HU,
    2. Reisaeter L,
    3. Irgens LM,
    4. Lie RT

    . Long term mortality of mothers and fathers after preeclampsia: population based cohort study. BMJ 2001; 323(7323):1213–1217. doi:10.1136/bmj.323.7323.1213

    OpenUrlAbstract/FREE Full Text
43. 43.↵
    1. O’Brien TE,
    2. Ray JG,
    3. Chan WS

    . Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 2003; 14(3):368–374. pmid:12859040

    OpenUrlCrossRefPubMed
44. 44.↵
    1. Williams D

    . Pregnancy: a stress test for life. Curr Opin Obstet Gynecol 2003; 15(6):465–471. doi:10.1097/01.gco.0000103846.69273.ba

    OpenUrlCrossRefPubMed
45. 45.↵
    1. Forest JC,
    2. Girouard J,
    3. Masse J, et al

    . Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol 2005; 105(6):1373–1380. doi:10.1097/01.AOG.0000163252.02227.f8

    OpenUrlCrossRefPubMed
46. 46.
    1. Ray JG,
    2. Vermeulen MJ,
    3. Schull MJ,
    4. Redelmeier DA

    . Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005; 366(9499):1797–1803. doi:10.1016/S0140-6736(05)67726-4

    OpenUrlCrossRefPubMed
47. 47.
    1. Smith GN,
    2. Pudwell J,
    3. Walker M,
    4. Wen SW

    . Ten-year, thirty-year, and lifetime cardiovascular disease risk estimates following a pregnancy complicated by preeclampsia. J Obstet Gynaecol Can 2012; 34(9):830–835. doi:10.1016/S1701-2163(16)35381-6

    OpenUrlCrossRefPubMed
48. 48.↵
    1. Veerbeek JH,
    2. Hermes W,
    3. Breimer AY, et al

    . Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension. Hypertension 2015; 65(3):600–606. doi:10.1161/HYPERTENSIONAHA.114.04850

    OpenUrlAbstract/FREE Full Text
49. 49.↵
    1. Savitz DA,
    2. Danilack VA,
    3. Elston B,
    4. Lipkind HS

    . Pregnancy-induced hypertension and diabetes and the risk of cardiovascular disease, stroke, and diabetes hospitalization in the year following delivery. Am J Epidemiol 2014; 180(1):41–44. doi:10.1093/aje/kwu118

    OpenUrlCrossRefPubMed
50. 50.↵
    1. Wilson BJ,
    2. Watson MS,
    3. Prescott GJ, et al

    . Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003; 326(7394):845. doi:10.1136/bmj.326.7394.845

    OpenUrlAbstract/FREE Full Text
51. 51.↵
    1. LeFevre ML; US Preventive Services Task Force

    . Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: US Preventive Services Task Force recommendation statement. Ann Intern Med 2014; 161(11):819–826. doi:10.7326/M14-1884

    OpenUrlCrossRefPubMed
52. 52.↵
    1. Arany Z,
    2. Elkayam U

    . Peripartum cardiomyopathy. Circulation 2016; 133(14):1397–1409. doi:10.1161/CIRCULATIONAHA.115.020491

    OpenUrlAbstract/FREE Full Text
53. 53.↵
    1. Hilfiker-Kleiner D,
    2. Haghikia A,
    3. Nonhoff J,
    4. Bauersachs J

    . Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J 2015; 36(18):1090–1097. doi:10.1093/eurheartj/ehv009

    OpenUrlCrossRefPubMed
54. 54.↵
    1. McNamara DM,
    2. Elkayam U,
    3. Alharethi R, et al. IPAC Investigators

    . Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol 2015; 66(8):905–914. doi:10.1016/j.jacc.2015.06.1309

    OpenUrlFREE Full Text
55. 55.↵
    1. Elkayam U

    . Risk of subsequent pregnancy in women with a history of peripartum cardiomyopathy. J Am Coll Cardiol 2014; 64(15):1629–1636. doi:10.1016/j.jacc.2014.07.961

    OpenUrlFREE Full Text
56. 56.↵
    1. Ginz B

    . Myocardial infarction in pregnancy. J Obstet Gynaecol Br Commonw 1970; 77(7):610–615. pmid:5433480

    OpenUrlPubMed
57. 57.↵
    1. Petitti DB,
    2. Sidney S,
    3. Quesenberry CP Jr.,
    4. Bernstein A

    . Incidence of stroke and myocardial infarction in women of reproductive age. Stroke 1997; 28(2):280–283. pmid:9040675

    OpenUrlAbstract/FREE Full Text
58. 58.↵
    1. Vijayaraghavan R,
    2. Verma S,
    3. Gupta N,
    4. Saw J

    . Pregnancy-related spontaneous coronary artery dissection. Circulation 2014; 130(21):1915–1920. doi:10.1161/CIRCULATIONAHA.114.011422

    OpenUrlFREE Full Text
59. 59.↵
    1. Burchill LJ,
    2. Lameijer H,
    3. Roos-Hesselink JW, et al

    . Pregnancy risks in women with pre-existing coronary artery disease, or following acute coronary syndrome. Heart 2015; 101(7):525–529. doi:10.1136/heartjnl-2014-306676

    OpenUrlAbstract/FREE Full Text
60. 60.↵
    1. James AH,
    2. Jamison MG,
    3. Biswas MS,
    4. Brancazio LR,
    5. Swamy GK,
    6. Myers ER

    . Acute myocardial infarction in pregnancy: a United States population-based study. Circulation 2006; 113(12):1564–1571. doi:10.1161/CIRCULATIONAHA.105.576751

    OpenUrlAbstract/FREE Full Text
61. 61.↵
    1. Nolan TE,
    2. Hankins GD

    . Myocardial infarction in pregnancy. Clin Obstet Gynecol 1989; 32(1):68–75. pmid:2661081

    OpenUrlPubMed
62. 62.↵
    1. Silversides CK,
    2. Grewal J,
    3. Mason J, et al

    . Pregnancy outcomes in women with heart disease: the CARPREG II Study. J Am Coll Cardiol 2018; 71(21):2419–2430. doi:10.1016/j.jacc.2018.02.076

    OpenUrlFREE Full Text
63. 63.↵
    1. Drenthen W,
    2. Boersma E,
    3. Balci A, et al. ZAHARA Investigators

    . Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 2010; 31(17):2124–2132. doi:10.1093/eurheartj/ehq200

    OpenUrlCrossRefPubMed
64. 64.↵
    1. Balci A,
    2. Sollie-Szarynska KM,
    3. van der Bijl AG, et al. ZAHARA-II investigators

    . Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart 2014; 100(17):1373–1381. doi:10.1136/heartjnl-2014-305597

    OpenUrlAbstract/FREE Full Text
65. 65.↵
    1. Lu CW,
    2. Shih JC,
    3. Chen SY, et al

    . Comparison of 3 risk estimation methods for predicting cardiac outcomes in pregnant women with congenital heart disease. Circ J 2015; 79(7):1609–1617. doi:10.1253/circj.CJ-14-1368

    OpenUrlCrossRefPubMed